SUSAR differs from a general SAE because it is

Enhance your knowledge of clinical trial principles with our ACRP GCP and Clinical Trial Principles Test. Utilize flashcards and multiple choice questions, complete with detailed explanations, to elevate your preparation and excel in your exam!

Multiple Choice

SUSAR differs from a general SAE because it is

Explanation:
SUSARs are defined by a combination of three ideas: the event is serious, it is suspected to be related to the investigational product, and it is unexpected based on what is already known about the product. This means the reaction is not only severe, but also potentially caused by the IP and not described in the current safety information (like the Investigator’s Brochure). If an event is clearly unrelated to the IP or is an already-described, anticipated reaction, it would not be a SUSAR—even if it’s serious. So the best description is that it’s suspected to be related to the IP and is unexpected.

SUSARs are defined by a combination of three ideas: the event is serious, it is suspected to be related to the investigational product, and it is unexpected based on what is already known about the product. This means the reaction is not only severe, but also potentially caused by the IP and not described in the current safety information (like the Investigator’s Brochure). If an event is clearly unrelated to the IP or is an already-described, anticipated reaction, it would not be a SUSAR—even if it’s serious. So the best description is that it’s suspected to be related to the IP and is unexpected.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy